Wolverine Trading’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82M | Buy |
17,609
+8,743
| +99% | +$904K | ﹤0.01% | 236 |
|
|
2025
Q1 | $1.05M | Sell |
8,866
-2,256
| -20% | -$267K | ﹤0.01% | 398 |
|
|
2024
Q4 | $943K | Sell |
11,122
-2,928
| -21% | -$248K | ﹤0.01% | 586 |
|
|
2024
Q3 | $1.26M | Buy |
+14,050
| New | +$1.26M | ﹤0.01% | 341 |
|
|
2024
Q2 | – | Sell |
-3,885
| Closed | -$310K | – | 1325 |
|
|
2024
Q1 | $310K | Sell |
3,885
-1,173
| -23% | -$93.6K | ﹤0.01% | 791 |
|
|
2023
Q4 | $403K | Sell |
5,058
-534
| -10% | -$42.5K | ﹤0.01% | 772 |
|
|
2023
Q3 | $391K | Sell |
5,592
-2,227
| -28% | -$156K | ﹤0.01% | 675 |
|
|
2023
Q2 | $572K | Buy |
+7,819
| New | +$572K | ﹤0.01% | 488 |
|
|
2023
Q1 | – | Sell |
-3,920
| Closed | -$302K | – | 1131 |
|
|
2022
Q4 | $302K | Sell |
3,920
-2,659
| -40% | -$205K | ﹤0.01% | 599 |
|
|
2022
Q3 | $290K | Buy |
+6,579
| New | +$290K | ﹤0.01% | 748 |
|